Suppr超能文献

药物辅助治疗服务的提供与创伤后应激障碍和阿片类药物使用障碍的退伍军人队列的死亡率之间的关联。

Associations between Medication Assisted Therapy Services Delivery and Mortality in a National Cohort of Veterans with Posttraumatic Stress Disorder and Opioid Use Disorder.

机构信息

Department of Mental Health, Veterans Affairs Medical Center, White River Junction, VT, USA.

Department of Mental Health, Geisel School of Medicine at Dartmouth College, Hanover, NH, USA.

出版信息

J Dual Diagn. 2020 Apr-Jun;16(2):228-238. doi: 10.1080/15504263.2019.1701218. Epub 2019 Dec 18.

Abstract

Opioid use disorder (OUD) is a notable concern in the United States (US) and strongly associated with mortality. There is a high prevalence of OUD in patients with posttraumatic stress disorder (PTSD) and the mortality associated with OUD may be exacerbated in patients with PTSD. Medication-assisted treatment (MAT) for OUD has become standard of care for OUD and has been shown to reduce mortality. However, there has been little study of MAT and mortality in patients with PTSD and OUD. We conducted a retrospective cohort study in U.S. veterans who had newly engaged in PTSD treatment, were diagnosed with OUD and were provided MAT for at least one day between 2004 and 2013. We assessed mortality for one year following the index diagnosis date. We calculated all-cause mortality as well as death by external cause, overdose plus suicide, overdose, and suicide rates per 100,000. We used hazard ratios (HR) and 95% confidence intervals (CI) to compare death rates between patients with high versus low adherence to MAT. We evaluated the impact of high versus low exposure to general substance abuse care. We considered a confidence interval that did not cross one to be significant. A total of 5,901 patients met inclusion criteria. Most patients were men and the average age was 43.3 years ( = 13.8). The all-cause mortality rate was 1,370 per 100,000 patients. High adherence to MAT resulted in a non-significant, decreased risk for death due to all-cause (HR = 0.73, 95% CI [0.47, 1.13]), external cause (HR = 0.71, 95% CI [0.38, 1.35]), and overdose or suicide (HR = 0.66, 95% CI [0.33, 1.35]). Patients with high exposure (≥ 60 days) to general substance abuse care were significantly less likely to die due to external cause (HR = 0.39, 95% CI [0.18, 0.85]) and overdose or suicide (HR = 0.31, 95% CI [0.12, 0.77]). In patients with PTSD and OUD, improved adherence to MAT and greater exposure to general substance abuse care may result in lower mortality. Studies with longer follow-up and larger sample sizes to assess the impact of MAT on suicide are needed to confirm our findings.

摘要

阿片类药物使用障碍(OUD)是美国(US)的一个显著关注点,与死亡率密切相关。创伤后应激障碍(PTSD)患者中 OUD 的患病率很高,而 OUD 相关的死亡率在 PTSD 患者中可能会加剧。药物辅助治疗(MAT)已成为 OUD 的标准治疗方法,并已证明可降低死亡率。然而,针对 PTSD 和 OUD 患者的 MAT 和死亡率的研究甚少。

我们在美国退伍军人中进行了一项回顾性队列研究,这些退伍军人在 2004 年至 2013 年间首次接受 PTSD 治疗,被诊断为 OUD,并接受了至少一天的 MAT。我们评估了从指数诊断日期起一年后的死亡率。我们计算了每 10 万人的全因死亡率以及因外部原因、过量加自杀、过量和自杀导致的死亡率。我们使用风险比(HR)和 95%置信区间(CI)来比较高与低 MAT 依从性患者的死亡率。我们评估了高与低接受一般物质滥用治疗的影响。我们认为不跨越一个置信区间的置信区间具有统计学意义。

共有 5901 名患者符合纳入标准。大多数患者为男性,平均年龄为 43.3 岁( = 13.8)。全因死亡率为每 10 万人中有 1370 人。高 MAT 依从性与全因死亡率(HR = 0.73,95%CI [0.47, 1.13])、外部原因死亡率(HR = 0.71,95%CI [0.38, 1.35])和过量或自杀死亡率(HR = 0.66,95%CI [0.33, 1.35])降低无关。高(≥ 60 天)暴露于一般物质滥用治疗的患者因外部原因(HR = 0.39,95%CI [0.18, 0.85])和过量或自杀(HR = 0.31,95%CI [0.12, 0.77])的死亡率显著降低。

在 PTSD 和 OUD 患者中,提高 MAT 依从性和增加一般物质滥用治疗的暴露量可能会降低死亡率。需要进行具有更长随访时间和更大样本量的研究来评估 MAT 对自杀的影响,以证实我们的发现。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验